$294 Million is the total value of Nextech Invest Ltd.'s 13 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PMVP | Sell | PMV PHARMACEUTICALS INC | $2,950,238 | +18.6% | 471,284 | -9.6% | 1.00% | -3.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
REVOLUTION MEDICINES INC | 8 | Q3 2023 | 44.0% |
EQRX INC | 8 | Q3 2023 | 23.5% |
TYRA BIOSCIENCES INC | 8 | Q3 2023 | 16.9% |
KINNATE BIOPHARMA INC | 8 | Q3 2023 | 14.0% |
CULLINAN ONCOLOGY INC | 8 | Q3 2023 | 5.3% |
PMV PHARMACEUTICALS INC | 8 | Q3 2023 | 8.4% |
ARVINAS INC | 8 | Q3 2023 | 6.2% |
SILVERBACK THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
KRONOS BIO INC | 8 | Q3 2023 | 5.2% |
THESEUS PHARMACEUTICALS INC | 8 | Q3 2023 | 2.3% |
View Nextech Invest Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-01 |
13F-HR/A | 2022-05-16 |
13F-HR | 2022-05-16 |
View Nextech Invest Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.